HER2-positive breast cancer progresses rapidly after pyrotinib resistance: acquired RET gene fusion and TP53 gene mutation are potential reasons
Article in Anti-Cancer Drugs (January 2023)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in Anti-Cancer Drugs (January 2023)
Article in Frontiers in Oncology (December 2021)
Article in Reactions Weekly (February 2021)